Cancer chemotherapy and biological response modifiers annual 21 / edited by G. Gianccone, R. Schilsky, P. Sondel
Publication details: Amsterdam : Elsevier, c2003Edition: 1st editionDescription: xix, 877 p. : ill. ; 27 cmISBN:- 0444514589
- 0921-4410
- QZ 266 C215 2002
Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Book Open Access | Health Sciences Library | QZ 266 C215 2002 (Browse shelf(Opens below)) | 1 | Available | MBAL22010350 |
Includes Bibliographical references and index
Contents
Introduction
I. Drugs
1. Thymidylates synthase inhibitors
2. New nucleoside analogue in clinical development
3. Anthracyclines
4. Tubulin-targeting agents
5. Topoisomerase I interactive agents
6. Topoisomerase II inhibitors
7. Farnesyltransferase inhibitors
8. Cyclin-depent kinases as targets for cancer therapy
9. DNA-binding agents
10. The evolving role of endocrine therapy for the treatment and prevention of breast cancer
11. New targets for cancer chemotherapy
II. Biological Response Modifiers
12. The graft-versus-turmor effect and escape of malignancy from immune regulation
13. Donor Lymphocyte infusions for hematopoietic malignancy
14. Diptheria toxin conjugate therapy of cancer
15. Genetical engineered T cells as Adoptive immunotherapy of cancer
16. Integrating IL-12 into therapeutic cancer vaccines
17. Immunotherapy for breast cancer
18. Immunotherapy of Melanoma
19. CEA loaded dendritic cell vaccines
III. Tumours
20. Lymphomas
21. Head and neck cancer
22. Cancers of the large bowel and hepatobiliary track
23. Malignant neuroendocrine tumors
24. Genitourinary Malignancies
25. Breast Cancer
26. Advances in the management of melanoma
27. Sarcomas
28. Brain Tumors
29. Biology and Therapy of Malignant solids tumors in childhood
30. Supportive Care
31. AIDS - associated malignancies
IV. Special Section - Lung Cancer
32. CT. screening for Lung Cnacer
33. Combined modality treatment of Lung cancer(NSCLC and SCLC)
34. Update on the systemic treatment of lung cancer
35. New targets for the treatment of advanced non-small cell lung cancer
36. Novel Therapies for the treatment of non-small cell lung cancer
There are no comments on this title.